Devatis GmbH

Name: Devatis GmbH
Address: Spitalstr. 22, Lörrach, Baden-Württemberg, 79539, DE
Telephone: 076217095720

Pharmaceutical Companies · Lörrach

Devatis GmbH is a pharmaceutical company based in Lörrach, Baden-Württemberg, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Content in German

The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.

Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.

Devatis GmbH – Address & Contact

Phone

Website

Email

Address

Spitalstr. 22
79539 Lörrach

Devatis GmbH Overview

Devatis GmbH is a pharmaceutical company based in Lörrach, Baden-Württemberg. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Activities & Products

Pharmaceutical companies such as Devatis GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).

Location & Contact

Devatis GmbH can be reached at the following address: Spitalstr. 22, 79539 Lörrach – Phone: 076217095720. For current information and enquiries, please contact the company directly.

More information: Pharmaunternehmen in Baden-Württemberg or all Pharmaunternehmen in Germany on Sanoliste.

Pharmazeutische Regulierung in Deutschland

Pharmaceutical companies such as Devatis GmbH are subject to one of the world's most stringent regulatory frameworks in Germany. The German Medicinal Products Act (AMG) governs the authorisation, manufacturing, distribution and monitoring of medicinal products. Market authorisation for new active substances falls under the responsibility of either the Federal Institute for Drugs and Medical Devices (BfArM) or the European Medicines Agency (EMA), depending on whether a national or centralised authorisation is sought.

Arzneimittelversorgung & Marktumfeld

With a revenue volume exceeding 50 billion euros, the German pharmaceutical market is one of the largest in Europe. Devatis GmbH, based in Lörrach, is part of this market. The supply chain from manufacturer through wholesaler to pharmacy is governed by Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). Since the entry into force of the Act for Greater Safety in the Medicinal Products Supply (GSAV), stricter requirements for the traceability of medicinal products also apply.

Pharmastandort Baden-Württemberg

Baden-Württemberg is a significant pharmaceutical location in Germany. Companies such as Devatis GmbH benefit from proximity to research institutions, university hospitals and well-developed infrastructure. The industry employs over 140,000 people in Germany and invests billions annually in research and development.

Frequently asked questions about Devatis GmbH

What does Devatis GmbH do?

Devatis GmbH produces als deutsche Tochtergesellschaft des türkischen Mutterkonzerns verschiedene Generika for den German Markt. Daat deckt sie the Therapiebereiche Antiasthmatika, Antibiotika, Antihypertonika and Antimykotika ab. Ferner produces sie Mittel for the Augenheilkande, Parkinson, at Krebserkrankungen and for the Psychiatrie.

What medicines does Devatis GmbH manufacture?

Devatis GmbH is a pharmaceutical company in Lörrach. Über Devatis GmbH Devatis GmbH is ein mornes and innovatives Softwareundernehmen, the sich on the development of digitalen Lösungen for verschiedene Geschäftsbereiche spezial Alle in Germany zugelassenen medicines are in the medicines-Datenbank des BfArM recherchierbar.

How are medicines approved in Germany?

Neue medicines benötigen vor dem Inverkehrbringen eine Zulassung durch the BfArM (national) or the EMA (europaweit). Der Zulassungsprozess umfasst the Prüfung of quality, Wirksamkeit and Unbedenklichkeit on Basis präklinischer and klinischer Stuthen. Die Nutzenbewertung after § 35a SGB V entscheidet about the Erstattung durch the gesetzlichen Krankenkassen.

What does GMP mean in pharmaceutical production?

GMP (Good Manufacturing Practice) bezeichnet the Gute manufacturingspraxis – ein System of qualitysstandards, the sicherstellt, thes medicines gleichbleibend after den gefortheten qualitysnormen hergestellt and geprüft are. Die GMP-Richtlinien are in the EU durch den EudraLex Volume 4 definiert.

Devatis GmbH on social media